Clinical Trial Update: A Long-term Study of AK102 in Patients With Hypercholesterolemia [Phase 2]

View source ↗

Summary

Phase 2 long-term study update of AK102 in patients with hypercholesterolemia has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hypercholesterolemia

Drugs mentioned

• AK102

Snippet

Sponsor: Akeso | Conditions: Hypercholesterolemia | Phase 2 | Status: COMPLETED